Share

    


Home / Search Results

Search Results

You searched for:

An expert ACCC Steering Committee shares 32 informed treatment and care delivery recommendations for the ideal care of patients with non-small cell lung cancer.
In addition to the global pandemic, ongoing lawsuits from referenced biologics' manufacturers suing biosimilar manufacturers are having a negative impact on the development and approval of new biosimilars.
This ACCC education program shares key highlights from a national survey of thoracic surgeons, radiation oncologists, and medical oncologists on the barriers that exist in the ideal management of patients with NSCLC.
Dr. Vijay Rao and Dr. Eric Stephen Rubenstein returned from a Global Cardio-Oncology Society meeting g with the realization that they could do much more to protect patients with cancer from potential cardiac toxicity of chemotherapy. The two shared one goal: to prevent the cancer survivor of today from becoming the heart failure patient of tomorrow.
In response to the increasing complexity of oncolytic agents, the associated economic burden on the patient and health system, and the intricacies associated with alternative payment models (APMs), I suggest the need for widespread establishment of chemotherapy stewardship services.
Learn how Advocate-Aurora Lutheran General Hospital, Ill., modified an unused space in its inpatient oncology unit to create an outpatient oncology symptom management treatment area. The program now sees cancer patients outside of traditional office hours, thereby reducing ED visits and hospitalizations.
Understanding both a patient’s need for support during the cancer journey and the importance for medical students to personally connect with those they care for led to the creation of Chemo Companions in 2016. Through this program, students assume a companion/support role with cancer patients currently receiving chemotherapy at one of Mount Sinai’s cancer centers.
Although many rural facilities in South Dakota do have infusion centers that administer anti-cancer therapies, these centers are generally not directly overseen by an oncologist or oncology trained advanced practice provider. Rather, local family practice or internal medicine physicians who are often unfamiliar with oncologic therapies oversee the administration of infusions.
Fertility preservation is an increasing concern for adolescent and young adult (AYA) patients with cancer. However, not all newly diagnosed males discuss fertility preservation with a healthcare provider before treatment. This quality improvement project describes the oncofertility program development that was part of a larger goal to develop an AYA oncology program at our institution, the University …
Though the incidence of AIDS-defining cancers has decreased with the use of antiretroviral therapy, numerous studies suggest that non-AIDS-defining cancers (cancers not previously associated with HIV and AIDS) appear to be increasing in incidence.